Efficient transduction and long-term retroviral expression of the melanoma-associated tumor antigen tyrosinase in CD34+ cord blood-derived dendritic cells

Gene Therapy

Volumn 9, Issue 22, 2002, Pages 1551-1560

  Temme, A ^a,b   Morgenroth, A ^a   Schmitz, M ^a   Weigle, B ^a   Rohayem, J ^a   Lindemann, D ^a   Fussel M ^a   Ehninger, G ^b   Rieber, E P ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Antigen presentation; CD34+ derived DCs; Immunotherapy; Retroviral expression

Indexed keywords

CANCER ANTIBODY; CD34 ANTIGEN; CHROMIUM; GREEN FLUORESCENT PROTEIN; HLA ANTIGEN; MELANOMA ANTIGEN; MONOPHENOL MONOOXYGENASE; RETROVIRUS VECTOR; VIRUS PROTEIN;

CANCER IMMUNOTHERAPY; CELL CLONE; CELL DIFFERENTIATION; CELL POPULATION; CISTRON; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DNA SEQUENCE; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSDUCTION; HEMATOPOIETIC STEM CELL; HUMAN; MELANOMA; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; STEM CELL; TRANSGENE; UMBILICAL CORD BLOOD; VESICULAR STOMATITIS VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS EXPRESSION;

ANTIGENS, CD34; ANTIGENS, NEOPLASM; CANCER VACCINES; CELL DIFFERENTIATION; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MELANOMA; MOLONEY MURINE LEUKEMIA VIRUS; MONOPHENOL MONOOXYGENASE; TIME FACTORS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; VESICULAR STOMATITIS-INDIANA VIRUS;

MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; ONCOVIRINAE; UNIDENTIFIED RETROVIRUS; VESICULAR STOMATITIS VIRUS;

EID: 0036857692     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301821     Document Type: Review

References (40)

1. + cells. Hum Gene Ther 1999; 10: 175-187.
2. Movassagh M et al. High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotype retroviral vectors and an improved clinically applicable protocol. Hum Gene Ther 1998; 9: 225-234.
3. + cell-derived human dendritic cells. Gene Therapy 2001; 8: 1427-1435.
4. + cells. Hum Gene Ther 2000; 11: 2483-2492.
5. Benchimol S et al. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell 1989; 57: 327-334.
6. Chen D, Shou C. Molecular cloning of a tumor-associated antigen recognized by monoclonal antibody 3H11. Biochem Biophys Res Commun 2001; 280: 99-103.
7. Brichard V et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1993; 178: 489-495.
8. Bakker AB et al. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 1994; 179: 1005-1009.
9. Coulie PG et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 1994; 180: 35-42.
10. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-921.
11. Inaba K, Metlay JP, Crowley MT, Steinman RM. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J Exp Med 1990; 172: 631-640.
12. Porgador A, Gilboa E. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J Exp Med 1995; 182: 255-260.
13. + T effector cells by dendritic cells pulsed with protein or selected peptides. Cancer Res 2000; 60: 4845-4849.
14. Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996; 184: 465-472.
15. Gong J et al. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gene Therapy 1997; 10: 1023-1028.
16. + hematopoetic progenitor cells. J Immunol 2000; 165: 4133-4140.
17. Reeves ME et al. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res 1996; 56: 5672-5677.
18. Drexler I et al. Modified vaccinia virus Ankara for delivery of human tyrosinase as melanoma-associated antigen: induction of tyrosinase- and melanoma-specific human leukocyte antigen A*0201-restricted cytotoxic T cells in vitro and in vivo. Cancer Res 1999; 59: 4955-4963.
19. Butterfield LH et al. Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus. J Immunol 1998; 161: 5607-5613.
20. Zitvogel L et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998; 5: 594-600.
21. Gong J, Chen D, Kashiwaba M, Kufe D. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells. Nat Med 1997; 5: 558-561.
22. Rasmussen R. Quantification on the LightCycler. In: Meurer S, Wittwer C, Nakagawara K (eds). Rapid Cycle Real-Time PCR: Methods and Application. Springer: Berlin, 2001, pp 21-34.
23. Visseren MJ et al. CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J Immunol 1995; 154: 3991-3998.
24. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992; 360: 258-261.
25. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNF alpha. J Exp Med 1996; 184: 695-706.
26. + hematopoietic progenitor cells. Blood 1996; 87: 1292-1302.
27. Klug CA, Cheshier S, Weissman IL. Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny. Blood 2000; 96: 894-901.
28. Cherry SR et al. Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol 2000; 20: 7419-7426.
29. Lorincz MC, Schubeler D, Groudine M. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation. Mol Cell Biol 2001; 21: 7913-7922.
30. Pannell D et al. Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J 2000; 19: 5884-5894.
31. Lindemann C et al. Down-regulation of retroviral transgene expression during differentiation of progenitor-derived dendritic cells. Exp Hematol 2002; 30: 150-157.
32. Li Z et al. Murine leukemia induced by retroviral gene marking. Science 2002; 296: 497.
33. Pawliuk R et al. Correction of sickle cell disease in transgenic mouse models by gene therapy. Science 2001; 294: 2368-2371.
34. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 1999; 283: 682-686.
35. Berberich-Siebelt S et al. C/EBPß enhances IL-4 but impairs IL-2 and IFN-g induction in T cells. Eur J Immunol 2000; 30: 2576-2585.
36. Dinev D et al. Extracellular signal regulated kinase 5 (ERK5) is required for the differentiation of muscle cells. EMBO Rep 2001; 9: 829-934.
37. Soneoka Y et al. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res 1995; 23: 628-633.
38. DuBridge RB et al. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987; 7: 379-387.
39. Lapointe R et al. Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes. Eur J Immunol 2000; 11: 3291-3298.
40. Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specifc activity. Anal Biochem 1979; 132: 6-13.